News for Exicure, Inc. (2H0.F)

Published at

Mar 3, 2021 1:46 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 2) ...

RMN.F RMN.BE MRK.PA MRK.MX MOR.F MOR.DE GSK.L GS7A.F GS7.SG GS7.MU GS7.F GS7.DE GS7.BE BSX.SG BSX.MX BSX.MU BSX.F BSX.BE 6MK.MU 6MK.F 6MK.DE 6MK.BE 4875.T 1OT.MU 1OT.F 1OT.BE TQ8.F TH.TO TCE2.MU TCE2.F TCE2.BE O2T.F O2T.BE E08A.F DPL.F CNB.F CNB.BE APH.SG APH.MU APH.F APH.BE 8STN.MU 8STN.F 8STN.BE 6GJ.F 69BN.SG 69BN.F 0OP.F 0OP.BE XP0.SG XP0.F RN3N.MU RN3N.F AMGN.BA AMG.MU AMG.F AMG.DE AMG.BE 2H0.MU 2H0.F 25K.SG 25K.MU 25K.F 25K.BE

Read more →
Published at

Mar 2, 2021 6:30 PM

by zacks.com

negative

negative

Exicure, Inc. (XCUR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Exicure, Inc. (XCUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

XCUR 2H0.MU 2H0.F

Read more →